|
Symbol Name ID |
Pld2
phospholipase D2 MGI:892877 |
Excel File
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| Pld1tm1.1Mafr/Pld1tm1.1Mafr Pld2tm1Yaka/Pld2tm1Yaka involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj |
no abnormal phenotype detected | J:192844 |
| Pld1tm3Mafr/Pld1tm3Mafr Pld2tm1(KOMP)Vlcg/Pld2tm1(KOMP)Vlcg involves: C57BL/6 * C57BL/6NTac |
abnormal enzyme/coenzyme activity | J:216114 |
| abnormal platelet activation | J:216114 | |
| decreased cerebral infarct size | J:216114 | |
| decreased susceptibility to induced thrombosis | J:216114 | |
| decreased susceptibility to ischemic brain injury | J:216114 | |
| normal homeostasis/metabolism phenotype | J:216114 | |
| Pld2tm1.1Gdp/Pld2+ Tg(APPSWE)2576Kha/0 involves: 129X1/SvJ * C57BL/6 * SJL |
normal behavior/neurological phenotype | J:166741 |
| enhanced contextual conditioning behavior | J:166741 | |
| Pld2tm1.1Gdp/Pld2tm1.1Gdp Tg(APPSWE)2576Kha/0 involves: 129X1/SvJ * C57BL/6 * SJL |
abnormal lipid level | J:166741 |
| abnormal synapse morphology | J:166741 | |
| normal behavior/neurological phenotype | J:166741 | |
| enhanced contextual conditioning behavior | J:166741 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/30/2024 MGI 6.23 |
|
|
|
||
Analysis Tools